← FDA DRUG APPROVALS

FDA ANDA · ANDA071635

INDOMETHACIN

Sponsor: WATSON LABS

APPLICATION
ANDA071635
TYPE
ANDA
ORIGINAL APPROVAL
1987-05-18
LATEST ACTION
1992-09-04
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

INDOMETHACINDiscontinued
INDOMETHACIN 50MG · CAPSULE · ORAL

Approval history

1992-09-04Labeling · Supplement 9AP
1992-01-03Labeling · Supplement 8AP
1989-06-08Labeling · Supplement 7AP
1989-02-02Labeling · Supplement 6AP
1987-05-18OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →